Report reveals big pharma middlemen inflating drug prices, reaping billions in excess revenue. • The Federal Trade Commission (FTC) released a report showing that pharmacy benefit managers (PBMs) ...

The U.S. Federal Trade Commission on Tuesday published the second part of its investigation into how prescription drug ...

January is a big time for drugmakers to hike prices. This year saw higher prices for 575 medications so far, including ...

Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in ...

Eli Lilly and other drugmakers are reportedly planning to urge the Trump administration to pause Medicare drug-price ...